Tag:
Servier
Latest Headlines
Latest Headlines
EU prepares tougher drug recall standards
In another response to questionable oversight by drug regulators in Europe, the EU is looking at more stringent regulations for requiring drug manufacturers to recall products.
Servier, founder face trial on Mediator charges
The French health ministry says Mediator caused at least 500 deaths.
Roche headlines autism alliance
A European research effort led by Roche ( $RHHBY ) and others to tackle autism spectrum disorders nailed down $38.7 million in financing for what will be a massive, 5-year project seeking to come up with new diagnostic and treatment options.
Mediator probe enlightens French public on drug risks
As public trust in drug regulation crumbles in France over alleged misdeeds in the marketing of Servier 's diabetes pill Mediator , politicians and health officials are scrambling to restore faith in a
MacroGenics pockets $20M in $450M deal with Servier
Taking another step forward after the failure of a late-stage trial of its lead drug last year, MacroGenics has bagged a pharma deal to fuel development of an immune-stimulating antibody against
UPDATED: Santaris wins as partner in Miragen's $352M deal
Santaris Pharma didn't make some of the headlines in the deal, but the Danish biotech factors prominently in its partner Miragen's microRNA pact with the French drugmaker Servier. While Boulder,
UPDATED: MiRagen lands $352M microRNA development pact with Servier
Boulder, CO-based miRagen has racked up its first big collaboration, inking a development pact with France's Servier for two of its top preclinical programs as well as a third, as yet unidentified,
Galapagos inks $367M deal in back-ended discovery pact with Servier
In an almost completely back-ended research deal, Belgium's Galapagos will rev up its drug discovery engine in search of new cancer treatments for France's Servier. Working with some established
French pharma boss singled out in Mediator probe
A major health scandal in France has ensnared a pharma bigwig. Jacques Servier, head one of the largest drugmakers in France, Servier Laboratories, made a first court appearance yesterday in
New Servier inspection coming from French watchdog
France's Servier is under renewed scrutiny from European regulators. The company, which came under fire over off-label use of its Mediator diabetes drug, has seen repeated inspections from European
